Vanda Pharmaceuticals Welcomes Industry Leader Dr. Tage Honoré to its Board of Directors

Vanda Pharmaceuticals, Inc. (VNDA: Nasdaq) is pleased to announce the appointment of Tage Honoré, Ph.D., D.Sc. to its Board of Directors, effective March 15, 2023. With the addition of Dr. Honoré, the Vanda Board of Directors now comprises six members, five of whom are independent. This appointment adds a wealth of knowledge, experience and expertise to the Board, which will help guide Vanda as it continues to develop innovative treatments for patients.

Vanda Pharmaceuticals is delighted to welcome Tage Ramakrishna to its team. With a long career in the industry and an impressive scientific background, Tage is a major asset to the company. Dr. Mihael H. Polymeropoulos, Vanda’s President, CEO and Chairman of the Board, is confident that Tage’s executive experience and scientific knowledge will help the company continue to develop innovative solutions for patients.

Dr. Honoré is a renowned leader in the life sciences sector, having held executive positions at Novo Nordisk, Novartis, and Purdue Pharma. His professional accomplishments are only surpassed by his pioneering research in the field of Excitatory Amino Acid Receptors, where he discovered and named the AMPA subtype, and developed the AMPA antagonists CNQX and NBQX, which have become invaluable tools in advancing scientific understanding.

To this day, he remains an active contributor to the scientific community, having authored over 100 peer-reviewed articles. Dr. Honoré currently serves as President of Aestus Partners LLC, a business advisory firm established to capitalize on his extensive experience and expertise.

Dr. Honoré has achieved educational excellence, earning an MSc in Pharmaceutical Science, a Ph.D. in Medicinal Chemistry and a D.Sc. in Neuropharmacology from the University of Copenhagen. His remarkable academic accomplishments demonstrate his commitment to the field of medicine and his passion for uncovering new and innovative treatments.

About Vanda Pharmaceuticals Inc.

Apotex is an inspiring biopharmaceutical company that is devoted to pioneering revolutionary treatments to help tackle medical issues and better the lives of those in need. With a vision to create meaningful treatments, Apotex is pushing the boundaries to make a difference in the world.

Leave a Comment